Liver involvement in inflammatory bowel disease: What should the clinician know? | World Journal of Hepatology | 2021 |
Antifungal Drug Interactions | | |
Infliximab and Golimumab | | 2014 |
Effects of metoclopramide on gastric motility measured by short-term bio-impedance | World Journal of Gastroenterology | 2009 |
Hepatic complications induced by immunosuppressants and biologics in inflammatory bowel disease | World Journal of Hepatology | 2017 |
Utilization and comparative effectiveness of caspofungin and voriconazole early after market approval in the U.S | PLoS ONE | 2014 |
New-generation, non-SSRI antidepressants: Drug-drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others | Medicinal Research Reviews | 2020 |
Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics' register GISEA | Clinical Rheumatology | 2018 |
Pharmacokinetics of Therapeutic Proteins | Methods and Principles in Medicinal Chemistry | 2017 |
Hidradenitis suppurativa gains increasing interest on World Wide Web: a source for patient information? | International Journal of Dermatology | 2017 |
Future Injectable Toxins | | 2017 |
New Formulations of Methylphenidate for the Treatment of Attention-Deficit/Hyperactivity Disorder: Pharmacokinetics, Efficacy, and Tolerability | CNS Drugs | 2017 |
The Safety of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Research | CNS Drugs | 2016 |
Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis | The Cochrane Library | 2016 |
Product Development Under FDA's Animal Rule: Understanding FDA's Expectations and Potential Implications for Traditional Development Programs | Therapeutic Innovation and Regulatory Science | 2016 |
Cost-effectiveness of Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir+Ribavirin for US Post-Liver Transplant Recurrent Genotype 1 HCV | Liver International | 2016 |
mTOR inhibitor-induced interstitial lung disease in cancer patients: Comprehensive review and a practical management algorithm | International Journal of Cancer | 2016 |
Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis | Emerging Infectious Diseases | 2016 |
Clinical efficacy and safety in relapsed/refractory mantle cell lymphoma: a systematic literature review | Clinical Lymphoma, Myeloma and Leukemia | 2015 |
Comparison of Adjuvant Radiation Therapy Alone Versus Radiation Therapy and Endocrine Therapy in Elderly Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Treated With Breast-Conserving Surgery | Clinical Breast Cancer | 2015 |
Food and Drug Administration Requirements for Clinical Studies in Pediatric Patients | Therapeutic Innovation and Regulatory Science | 2015 |
Signal for Thrombosis with Eltrombopag and Romiplostim: A Disproportionality Analysis of Spontaneous Reports Within VigiBase® | Drug Safety | 2015 |
Assessment of blood-brain barrier penetration of miltefosine used to treat a fatal case of granulomatous amebic encephalitis possibly caused by an unusual Balamuthia mandrillaris strain | Parasitology Research | 2015 |
Hepatic Disposition of Gemfibrozil and Its Major Metabolite Gemfibrozil 1-O-β-Glucuronide | Molecular Pharmaceutics | 2015 |
Clinical trials in youth-onset type 2 diabetes: needs, barriers, and options | Current Diabetes Reports | 2015 |
Understanding the reasons for delayed referral for intrathecal baclofen therapy in pediatric patients with severe spasticity | Child's Nervous System | 2015 |
Reduction in Medication Errors: The Fentora Case Study | Therapeutic Innovation and Regulatory Science | 2015 |
US Food and Drug Administration Web Site: A Primer for Pharmacists | Hospital Pharmacy | 2015 |
Riociguat: a novel new drug for treatment of pulmonary hypertension | Pharmacotherapy | 2015 |
Regulatory withdrawal of medicines marketed with uncertain benefits: the bevacizumab case study | Journal of Pharmaceutical Policy and Practice | 2015 |
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis | The Cochrane Library | 2015 |
Gadoxetic acid disodium (Gd-EOBDTPA)-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: a meta-analysis | Journal of Magnetic Resonance Imaging | 2014 |
Trastuzumab-containing regimens for metastatic breast cancer | The Cochrane Library | 2014 |
Current Antifungal Agents for Treatment of Central Nervous System Infections | Current Fungal Infection Reports | 2014 |
Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis | | 2014 |
Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administration | Journal of Clinical Pharmacology | 2014 |
Vemurafenib significantly decreases glomerular filtration rate | Journal of the European Academy of Dermatology and Venereology | 2014 |
Efectos cardiovasculares de fingolimod en el tratamiento de la esclerosis múltiple | Revista Colombiana De Cardiologia | 2013 |
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis | The Cochrane Library | 2013 |
Adverse event reporting patterns of newly approved drugs in the USA in 2006: an analysis of FDA Adverse Event Reporting System data | Drug Safety | 2013 |
Medication pain management in the elderly: unique and underutilized analgesic treatment options | Clinical Therapeutics | 2013 |
The utility of modeling and simulation in drug development and regulatory review | Journal of Pharmaceutical Sciences | 2013 |
Update on the sexual impact of treatment for benign prostatic hyperplasia | Current Urology Reports | 2012 |
Antihistamines in ocular allergy: are they all created equal? | Current Allergy and Asthma Reports | 2011 |
Neue Ansätze in der pharmakologischen Behandlung der Schizophrenie | Psychiatrie Und Psychotherapie | 2011 |
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis | | 2011 |
Darunavir, a New PI with Dual Mechanism: From a Novel Drug Design Concept to New Hope against Drug-Resistant HIV | Methods and Principles in Medicinal Chemistry | 2011 |
Impact of pharmacometric analyses on new drug approval and labelling decisions: a review of 198 submissions between 2000 and 2008 | Clinical Pharmacokinetics | 2011 |
The risk of death among adult participants in trials of antipsychotic drugs in schizophrenia | European Neuropsychopharmacology | 2010 |
Changes in glitazone use among office-based physicians in the U.S., 2003-2009 | Diabetes Care | 2010 |
Solubilization of vorinostat by cyclodextrins | Journal of Clinical Pharmacy and Therapeutics | 2010 |
Abatacept for rheumatoid arthritis: a Cochrane systematic review | Journal of Rheumatology | 2010 |
Abatacept for rheumatoid arthritis | The Cochrane Library | 2009 |
Ambrisentan | Drugs | 2008 |
Adverse drug interactions in dentistry | Periodontology 2000 | 2008 |
Determination of the antidepressant mirtazapine and its two main metabolites in human plasma by liquid chromatography with fluorescence detection | Analytica Chimica Acta | 2006 |